New pancreatic cancer pill could reshape treatment as early trial results stun researchers | Angelica Stabile, Fox News
A new drug for pancreatic cancer is showing promise in early testing.
Daraxonrasib is a daily pill designed to block cancer signals linked to the RAS gene. It https://t.co/8Fh8FnU5CI
— Owen Gregorian (@OwenGregorian)
May 21, 2026
from http://twitter.com/OwenGregorian
via IFTTT